A novel nonthermal energy source for surgical epicardial atrial ablation: irreversible electroporation.

BACKGROUND All currently used energy sources in surgical ablation for atrial fibrillation create lesions via thermal injury. We report for the first time the in vivo results of a new nonthermal modality of epicardial atrial ablation called irreversible electroporation (IRE). IRE utilizes a sequence of electrical pulses that produce permanent nonthermal damage to tissue in a few seconds with sharp borders between affected and unaffected regions. METHODS Five pigs underwent beating heart surgical epicardial ablations of their right and/or left atrial appendages, utilizing a sequence of 8, 16, or 32 direct current pulses of 1500 to 2000 V, 100 micros each, at a frequency of 5 per second, applied between two 4-cm long parallel electrodes with an IRE pulse generator. Local temperature measurements were performed during ablations followed by electrical isolation testing by pacing. Animal hearts were excised 24 hours after surgery and processed histologically to evaluate the degree of myocardial tissue necrosis and transmurality. RESULTS A clear demarcation line between ablated and normal tissue, with no tissue disruption or charring, was observed on gross inspection of all lesions. Staining results showed complete transmural destruction of atrial tissue at the site of the electrode application in all 10 atrial lesions, measuring a mean of 0.9 cm in depth. Each 3- to 3.5-cm long lesion was created in 1 to 4 seconds with no local temperature change and with demonstration of electrical isolation. CONCLUSIONS We propose a new modality to perform atrial ablations, which holds the potential of providing very swift, precise, and complete transmurality with no local heating effects.

[1]  J. Gehl,et al.  Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. , 2003, Acta physiologica Scandinavica.

[2]  H. Coster,et al.  A quantitative analysis of the voltage-current relationships of fixed charge membranes and the associated property of "punch-through". , 1965, Biophysical journal.

[3]  A. Tortolani,et al.  Surgical Treatment of Atrial Fibrillation Using Argon-Based Cryoablation During Concomitant Cardiac Procedures , 2005, Circulation.

[4]  S. Barnett,et al.  Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. , 2006, The Journal of thoracic and cardiovascular surgery.

[5]  K. Müller,et al.  Histopathology of intraoperatively induced linear radiofrequency ablation lesions in patients with chronic atrial fibrillation. , 2005, European heart journal.

[6]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[7]  L. Mir,et al.  [Electrochemotherapy, a new antitumor treatment: first clinical trial]. , 1991, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[8]  R. Gallotti,et al.  Left main coronary arterial lesion after microwave epicardial ablation. , 2003, The Annals of thoracic surgery.

[9]  J. Lablanche,et al.  Circumflex artery stenosis induced by intraoperative radiofrequency ablation. , 2003, The Annals of thoracic surgery.

[10]  Boris Rubinsky,et al.  Cancer Cells Ablation with Irreversible Electroporation , 2005, Technology in cancer research & treatment.

[11]  R. Damiano,et al.  Microwave ablation for atrial fibrillation: dose-response curves in the cardioplegia-arrested and beating heart. , 2006, The Annals of thoracic surgery.

[12]  Ernst Wolner,et al.  Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: results of a multicenter trial. , 2005, The Journal of thoracic and cardiovascular surgery.

[13]  J. Cummings,et al.  Alternative Energy Sources for the Ablation of Arrhythmias , 2005, Pacing and clinical electrophysiology : PACE.

[14]  Boris Rubinsky,et al.  In vivo results of a new focal tissue ablation technique: irreversible electroporation , 2006, IEEE Transactions on Biomedical Engineering.

[15]  O. Farish,et al.  Pulsed electric field inactivation of diarrhoeagenic Bacillus cereus through irreversible electroporation , 2000, Letters in applied microbiology.

[16]  E. Neumann,et al.  Permeability changes induced by electric impulses in vesicular membranes , 1972, The Journal of Membrane Biology.

[17]  W. Briggs,et al.  Epicardial beating heart cryoablation using a novel argon-based cryoclamp and linear probe. , 2006, The Journal of thoracic and cardiovascular surgery.

[18]  J. Ramires,et al.  Effectiveness of the Maze Procedure Using Cooled-Tip Radiofrequency Ablation in Patients With Permanent Atrial Fibrillation and Rheumatic Mitral Valve Disease , 2005, Circulation.

[19]  D. Ross,et al.  Comparison of epicardial and endocardial linear ablation using handheld probes. , 2003, The Annals of thoracic surgery.

[20]  T. Santiago,et al.  Epicardial radiofrequency applications: in vitro and in vivo studies on human atrial myocardium. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  N. Doll,et al.  Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high? , 2003, The Journal of thoracic and cardiovascular surgery.

[22]  James C. Weaver,et al.  Electroporation of cells and tissues , 2000 .

[23]  M. Oz,et al.  The technology in use for the surgical ablation of atrial fibrillation. , 2002, Seminars in thoracic and cardiovascular surgery.

[24]  M. Allessie,et al.  Evaluation of epicardial microwave ablation lesions: histology versus electrophysiology. , 2004, The Annals of thoracic surgery.

[25]  Nader Moazami,et al.  A New Era in the Surgical Treatment of Atrial Fibrillation: The Impact of Ablation Technology and Lesion Set on Procedural Efficacy , 2006, Annals of surgery.

[26]  J. Maessen,et al.  Post-mortem histologic evaluation of microwave lesions after epicardial pulmonary vein isolation for atrial fibrillation. , 2005, The Annals of thoracic surgery.